{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:50:17Z","timestamp":1792713017874,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.healun.2021.10.016","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T14:22:31Z","timestamp":1635430951000},"page":"208-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: Risk factors and management"],"prefix":"10.1016","volume":"41","author":[{"given":"Keren","family":"Rosen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Raanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gili","family":"Kenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudi","family":"Misgav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aharon","family":"Lubetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanely","family":"Niznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Sch\u00e4fers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Segel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Agmon-Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2021.10.016_bib0001","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome","volume":"4","author":"Myakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.healun.2021.10.016_bib0002","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome: a population-based study","volume":"71","author":"Duarte-Garc\u00eda","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.healun.2021.10.016_bib0003","first-page":"929","article-title":"The interaction between anti-Ro\/SSA and anti-La\/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic","volume":"35","author":"Agmon-Levin","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.healun.2021.10.016_bib0004","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10067-014-2486-5","article-title":"The spectrum between antiphospholipid syndrome and systemic lupus erythematosus","volume":"33","author":"Agmon-Levin","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.healun.2021.10.016_bib0005","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.semarthrit.2015.09.005","article-title":"Cardiac involvement in antiphospholipid syndrome: the diagnostic role of noninvasive cardiac imaging","volume":"45","author":"Mavrogeni","year":"2016","journal-title":"Semin Arthritis Rheu"},{"key":"10.1016\/j.healun.2021.10.016_bib0006","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11926-014-0478-8","article-title":"Pulmonary hypertension in antiphospholipid syndrome","volume":"17","author":"Zuily","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.healun.2021.10.016_bib0007","doi-asserted-by":"crossref","first-page":"D41","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2021.10.016_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","article-title":"Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients","volume":"96","author":"Vianna","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.healun.2021.10.016_bib0009","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1183\/13993003.01792-2016","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature","volume":"49","author":"Ende-Verhaar","year":"2017","journal-title":"Eur Respirat J"},{"key":"10.1016\/j.healun.2021.10.016_bib0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11739-018-02021-z","article-title":"Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis","volume":"14","author":"Cheng","year":"2019","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.healun.2021.10.016_bib0011","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1055\/s-0039-1692428","article-title":"Antiphospholipid syndrome in chronic thromboembolic pulmonary hypertension: a well-defined subgroup of patients","volume":"119","author":"Jiang","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.healun.2021.10.016_bib0012","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/resp.13618","article-title":"Non-invasive screening using ventilatory gas analysis to distinguish between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension","volume":"25","author":"Akizuki","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.healun.2021.10.016_bib0013","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2018.08.079","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH): updated recommendations from the Cologne Consensus Conference 2018","volume":"272","author":"Wilkens","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2021.10.016_bib0014","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2021.10.016_bib0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1378\/chest.81.2.151","article-title":"Longterm follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data","volume":"81","author":"Riedel","year":"1982","journal-title":"Chest"},{"key":"10.1016\/j.healun.2021.10.016_bib0016","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1177\/0961203318810427","article-title":"Pulmonary thromboendarterectomy is a curative resolution for chronic thromboembolic pulmonary hypertension associated with antiphospholipid syndrome: a retrospective cohort study","volume":"27","author":"Li","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.healun.2021.10.016_bib0017","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/resp.12883","article-title":"Prognostic and pathophysiological marker for patients with chronic thromboembolic pulmonary hypertension: Usefulness of diffusing capacity for carbon monoxide at diagnosis","volume":"22","author":"Suda","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.healun.2021.10.016_bib0018","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ejcts\/ezt572","article-title":"Outcomes of patients with antiphospholipid syndrome after pulmonary endarterectomy","volume":"46","author":"Camous","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2021.10.016_bib0019","first-page":"528","article-title":"Pulmonary endarterectomy surgery for chronic thromboembolic pulmonary hypertension: a small-volume national referral center experience","volume":"21","author":"Segel","year":"2019","journal-title":"IMAJ"},{"key":"10.1016\/j.healun.2021.10.016_bib0020","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1067\/mtc.2002.127313","article-title":"Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy","volume":"124","author":"Thistlethwaite","year":"2002","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.healun.2021.10.016_bib0021","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1160\/TH04-12-0839","article-title":"Antibody profiles for the diagnosis of antiphospholipid syndrome","volume":"93","author":"Pengo","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.healun.2021.10.016_bib0022","first-page":"1313","article-title":"Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension","volume":"25","author":"Martinuzzo","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.healun.2021.10.016_bib0023","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/686011","article-title":"Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension","volume":"6","author":"Matthews","year":"2016","journal-title":"Pulm Circ"},{"key":"10.1016\/j.healun.2021.10.016_bib0024","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1183\/09059180.00007309","article-title":"Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology","volume":"19","author":"Humbert","year":"2010","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.healun.2021.10.016_bib0025","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1034\/j.1399-3003.2000.15.03.x","article-title":"Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis","volume":"15","author":"Egermayer","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2021.10.016_bib0026","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH) results from an international prospective registry","volume":"124","author":"Pepke-Zaba","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2021.10.016_bib0027","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11926-014-0494-8","article-title":"The significance and management of thrombocytopenia in antiphospholipid syndrome","volume":"17","author":"Artim-Esen","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.healun.2021.10.016_bib0028","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1191\/0961203305lu2145rr","article-title":"Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis","volume":"14","author":"Atsumi","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.healun.2021.10.016_bib0029","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/09537104.2017.1280150","article-title":"The role of platelets in antiphospholipid syndrome","volume":"28","author":"Baroni","year":"2017","journal-title":"Platelets"},{"key":"10.1016\/j.healun.2021.10.016_bib0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jth.13947","article-title":"Thrombocytopenia in high-risk patients with antiphospholipid syndrome","volume":"16","author":"Pontara","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.healun.2021.10.016_bib0031","article-title":"Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study","author":"Pardos-Gea","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.healun.2021.10.016_bib0032","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2014.03.002","article-title":"14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome","volume":"13","author":"Cervera","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.healun.2021.10.016_bib0033","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1510\/icvts.2009.221630","article-title":"Impact of high titre of antiphospholipid antibodies on postoperative outcome following pulmonary endarterectomy","volume":"10","author":"D'Armini","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.healun.2021.10.016_bib0034","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11239-020-02260-y","article-title":"Platelet count trends and response to fondaparinux in a cohort of heparin-induced thrombocytopenia suspected patients after pulmonary endarterectomy","volume":"51","author":"Li","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.healun.2021.10.016_bib0035","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1538-7836.2009.03335.x","article-title":"False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus","volume":"7","author":"Pauzner","year":"2009","journal-title":"J Thromb Haemost"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821025699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821025699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:42:45Z","timestamp":1760949765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249821025699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1053249821025699"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2021.10.016","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: Risk factors and management","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2021.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}